Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series

Ketty Peris; Rodolfo Capizzi; Sara Tambone; Maria C. Fargnoli

Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series

Ketty Peris, Rodolfo Capizzi, Sara Tambone, Maria C. Fargnoli

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

In clinical studies, imiquimod 3.75% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or balding scalp. The aim of this study was to evaluate imiquimod 3.75% in a real-life clinical setting.

Lingua originale	English
pagine (da-a)	N/A-N/A
Rivista	GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA
Stato di pubblicazione	Pubblicato - 2015

Keywords

actinic keratosis

Altri file e collegamenti

Link a IRIS PubliCatt

Fingerprint Entra nei temi di ricerca di 'Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series'. Insieme formano una fingerprint unica.

Cita questo

@article{a5fe8dddc14840a99be898cfc30c5b23,

title = "Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series",

abstract = "In clinical studies, imiquimod 3.75% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or balding scalp. The aim of this study was to evaluate imiquimod 3.75% in a real-life clinical setting.",

keywords = "actinic keratosis, actinic keratosis",

author = "Ketty Peris and Rodolfo Capizzi and Sara Tambone and Fargnoli, {Maria C.}",

year = "2015",

language = "English",

pages = "N/A--N/A",

journal = "GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA",

issn = "1827-1820",

publisher = "Torino : Edizioni Minerva Medica",

}

TY - JOUR

T1 - Clinical experience of imiquimod 3.75% for actinic keratosis: results from a case series

AU - Peris, Ketty

AU - Capizzi, Rodolfo

AU - Tambone, Sara

AU - Fargnoli, Maria C.

PY - 2015

Y1 - 2015

N2 - In clinical studies, imiquimod 3.75% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or balding scalp. The aim of this study was to evaluate imiquimod 3.75% in a real-life clinical setting.

AB - In clinical studies, imiquimod 3.75% was shown to detect and treat actinic keratosis (AK) lesions across an entire sun-exposed field such as the full face or balding scalp. The aim of this study was to evaluate imiquimod 3.75% in a real-life clinical setting.

KW - actinic keratosis

UR - http://hdl.handle.net/10807/72789

M3 - Article

SP - N/A-N/A

JO - GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

JF - GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

SN - 1827-1820

ER -